You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel recommends Aimmune's peanut allergy treatment

CNBC's Meg Tirrell joins "Closing Bell" to report the latest decision from an outside adivsory panel to the FDA voting in favor of what could be the first-approved peanut allergy treatment from Aimmune Therapeutics.

UP NEXT

UP NEXT

Recent Videos

Featured Partners

image beaconimage beaconimage beacon